google_counter
Prostate Cancer Treatment with Lutetium-177 PSMA (688410) | Medipol Mega University Hospital Istanbul - BookingHealth
{"translation_price":"50","translation_doc_price":"40","child_coefficient":"1.1","transfer_price":"2.00","transfer_price_vip":"5.00","constant_transfer_price_vip":350,"constant_transfer_price":150,"constant_transfer_distanse":60,"type":"treatment","program_full_story":"<ul>\n\t<li>Initial presentation in the clinic<\/li>\n\t<li>history taking<\/li>\n\t<li>general clinical examination<\/li>\n\t<li>laboratory tests:\n\t<ul>\n\t\t<li>complete blood count<\/li>\n\t\t<li>biochemical analysis of blood<\/li>\n\t\t<li>urinalysis<\/li>\n\t\t<li>TSH-basal, fT3, fT4<\/li>\n\t\t<li>PSA blood test<\/li>\n\t\t<li>tests for urogenital infections<\/li>\n\t\t<li>indicators of inflammation<\/li>\n\t\t<li>indicators of blood coagulation<\/li>\n\t<\/ul>\n\t<\/li>\n\t<li>ultrasound scan of the urogenital system<\/li>\n\t<li>renal scintigraphy<\/li>\n\t<li>PSMA PET-CT (if indicated)<\/li>\n\t<li>PSMA treatment<\/li>\n\t<li>full body scintigraphy after 24 hours<\/li>\n\t<li>full body scintigraphy after 48&nbsp;hours<\/li>\n\t<li>symptomatic treatment<\/li>\n\t<li>cost of essential medicines<\/li>\n\t<li>nursing services<\/li>\n\t<li>elaboration of further recommendations<\/li>\n\t<li>stay in the hospital with full board&nbsp;<\/li>\n\t<li>accommodation in a room with 2 beds<\/li>\n<\/ul>\n<div class=\"program_how_program_going mt-4\"><h4>How program is carried out<\/h4><p style=\"text-align:justify\"><strong>During the first visit<\/strong>,&nbsp;the doctor will carry out a general physical examination and go through the results of your previous laboratory and instrumental tests. After that, you will undergo any necessary additional tests, such as an assessment of your liver and kidney function, a scintigraphy of your skeleton and salivary glands, a PSMA PET\/CT (additional cost). This will allow the doctor to calculate your individual dosage of the radionuclide.<\/p>\n\n<p style=\"text-align:justify\"><strong>PSMA therapy with Lutetium-177<\/strong>&nbsp;is carried out via intravenous administration of a solution containing the radioactive isotope, Lutetium-177. The solution is injected through a catheter. This is a short procedure, as the infusion usually takes no more than 20 minutes.<\/p>\n\n<p style=\"text-align:justify\">During the procedure, you will need to apply cooling bags to your salivary glands, as Lutetium-177 partially accumulates in the salivary glands, affecting their function and causing a dry mouth. You will also receive intravenous saline solutions to protect your kidneys.<\/p>\n\n<p style=\"text-align:justify\">After the infusion of Lutetium-177, you will stay in a specially equipped (radiation-shielded) ward for 48 hours. The drug is quickly excreted by the kidneys, and after 48 hours you will no longer be dangerous to others. During these 48 hours, you can read, use a mobile phone, tablet or computer &ndash; none of these devices will be a source of radiation in the future.<\/p>\n\n<p style=\"text-align:justify\"><strong>Follow-up examinations<\/strong>&nbsp;include whole-body scintigraphy and computed tomography in 24 hours, and then again 48 hours after the procedure.<\/p>\n<\/div><div class=\"program_required_documents mt-4\"><h4>Required documents<\/h4><ul>\n\t<li style=\"text-align: justify;\">Medical records<\/li>\n\t<li style=\"text-align: justify;\">MRI\/CT scan (not older than 3 months)<\/li>\n\t<li style=\"text-align: justify;\">Biopsy results (if available)<\/li>\n<\/ul>\n<\/div>","program_full_story_crm":"<ul>\n\t<li>Initial presentation in the clinic<\/li>\n\t<li>history taking<\/li>\n\t<li>general clinical examination<\/li>\n\t<li>laboratory tests:\n\t<ul>\n\t\t<li>complete blood count<\/li>\n\t\t<li>biochemical analysis of blood<\/li>\n\t\t<li>urinalysis<\/li>\n\t\t<li>TSH-basal, fT3, fT4<\/li>\n\t\t<li>PSA blood test<\/li>\n\t\t<li>tests for urogenital infections<\/li>\n\t\t<li>indicators of inflammation<\/li>\n\t\t<li>indicators of blood coagulation<\/li>\n\t<\/ul>\n\t<\/li>\n\t<li>ultrasound scan of the urogenital system<\/li>\n\t<li>renal scintigraphy<\/li>\n\t<li>PSMA PET-CT (if indicated)<\/li>\n\t<li>PSMA treatment<\/li>\n\t<li>full body scintigraphy after 24 hours<\/li>\n\t<li>full body scintigraphy after 48&nbsp;hours<\/li>\n\t<li>symptomatic treatment<\/li>\n\t<li>cost of essential medicines<\/li>\n\t<li>nursing services<\/li>\n\t<li>elaboration of further recommendations<\/li>\n\t<li>stay in the hospital with full board&nbsp;<\/li>\n\t<li>accommodation in a room with 2 beds<\/li>\n<\/ul>\n<div class=\"program_how_program_going mt-4\"><h4>How program is carried out<\/h4><p style=\"text-align:justify\"><strong>During the first visit<\/strong>,&nbsp;the doctor will carry out a general physical examination and go through the results of your previous laboratory and instrumental tests. After that, you will undergo any necessary additional tests, such as an assessment of your liver and kidney function, a scintigraphy of your skeleton and salivary glands, a PSMA PET\/CT (additional cost). This will allow the doctor to calculate your individual dosage of the radionuclide.<\/p>\n\n<p style=\"text-align:justify\"><strong>PSMA therapy with Lutetium-177<\/strong>&nbsp;is carried out via intravenous administration of a solution containing the radioactive isotope, Lutetium-177. The solution is injected through a catheter. This is a short procedure, as the infusion usually takes no more than 20 minutes.<\/p>\n\n<p style=\"text-align:justify\">During the procedure, you will need to apply cooling bags to your salivary glands, as Lutetium-177 partially accumulates in the salivary glands, affecting their function and causing a dry mouth. You will also receive intravenous saline solutions to protect your kidneys.<\/p>\n\n<p style=\"text-align:justify\">After the infusion of Lutetium-177, you will stay in a specially equipped (radiation-shielded) ward for 48 hours. The drug is quickly excreted by the kidneys, and after 48 hours you will no longer be dangerous to others. During these 48 hours, you can read, use a mobile phone, tablet or computer &ndash; none of these devices will be a source of radiation in the future.<\/p>\n\n<p style=\"text-align:justify\"><strong>Follow-up examinations<\/strong>&nbsp;include whole-body scintigraphy and computed tomography in 24 hours, and then again 48 hours after the procedure.<\/p>\n<\/div>","is_ambulant":"0","bh_fee":"0","only_for_children":"2","no_service":"0","with_prepayment":"1","show_calculator":"1","paket_type":"1","btn_type":"2","clinic_icon":"5ffffc5395c03.jpg","city":"Istanbul","clinic_site":"https:\/\/www.medipol.com.tr\/en\/","department_recommend":"0","country":"Turkey","country_id":"10","clinic_name":"Medipol Mega University Hospital Istanbul","cinic_name":"Medipol Mega University Hospital Istanbul","department_id":"3920","duration":"5","direction":"Nuclear Medicine","min_duration":0,"clinic_id":"1377","paketPrice":0,"paket":"<ul>\n <li>Interpreter up to 17 hours<\/li>\n <li>Translation up to 10 pages<\/li>\n <li>Visa support<\/li>\n\n \n<\/ul>","title":"Prostate Cancer Treatment with Lutetium-177 PSMA","price":{"val":25999,"type":"val"},"price_surcharge":0,"price_surcharge_clear":0,"extra_service_clinic":[{"id":"attendant_place","title":"Accommodation for the accompanying person ","parent":"duration","type":"count_val","val":"90.00"}],"extra_service":[],"translation_hours":"0","translation_doc_count":null,"roads":[{"id":"31","distance":"33","airport_title":"Istanbul"},{"id":"32","distance":"165","airport_title":"Bursa"},{"id":"33","distance":"480","airport_title":"Ankara"}],"pakets":[],"lang":{"day":"Day","days":"days","ambulatory":"Outpatient","stationaryProgram":"Inpatient"}}

Prostate Cancer Treatment with Lutetium-177 PSMA in Medipol Mega University Hospital Istanbul

Medipol Mega University Hospital Istanbul

Istanbul, Turkey
Program id # 688410
Doctor photo
Prof. Dr. med. Tamer Atasever
Department of Nuclear Medicine
Specialized in: nuclear medicine

The program includes:

  • Initial presentation in the clinic
  • history taking
  • general clinical examination
  • laboratory tests:
    • complete blood count
    • biochemical analysis of blood
    • urinalysis
    • TSH-basal, fT3, fT4
    • PSA blood test
    • tests for urogenital infections
    • indicators of inflammation
    • indicators of blood coagulation
  • ultrasound scan of the urogenital system
  • renal scintigraphy
  • PSMA PET-CT (if indicated)
  • PSMA treatment
  • full body scintigraphy after 24 hours
  • full body scintigraphy after 48 hours
  • symptomatic treatment
  • cost of essential medicines
  • nursing services
  • elaboration of further recommendations
  • stay in the hospital with full board 
  • accommodation in a room with 2 beds

How program is carried out

During the first visit, the doctor will carry out a general physical examination and go through the results of your previous laboratory and instrumental tests. After that, you will undergo any necessary additional tests, such as an assessment of your liver and kidney function, a scintigraphy of your skeleton and salivary glands, a PSMA PET/CT (additional cost). This will allow the doctor to calculate your individual dosage of the radionuclide.

PSMA therapy with Lutetium-177 is carried out via intravenous administration of a solution containing the radioactive isotope, Lutetium-177. The solution is injected through a catheter. This is a short procedure, as the infusion usually takes no more than 20 minutes.

During the procedure, you will need to apply cooling bags to your salivary glands, as Lutetium-177 partially accumulates in the salivary glands, affecting their function and causing a dry mouth. You will also receive intravenous saline solutions to protect your kidneys.

After the infusion of Lutetium-177, you will stay in a specially equipped (radiation-shielded) ward for 48 hours. The drug is quickly excreted by the kidneys, and after 48 hours you will no longer be dangerous to others. During these 48 hours, you can read, use a mobile phone, tablet or computer – none of these devices will be a source of radiation in the future.

Follow-up examinations include whole-body scintigraphy and computed tomography in 24 hours, and then again 48 hours after the procedure.

Required documents

  • Medical records
  • MRI/CT scan (not older than 3 months)
  • Biopsy results (if available)

Service

Price from:
Type of program :
Price for 1 day:
Expected duration of the program:
The minimum duration of the program:
Select

You may also book:

Hospital directly:
Saving:
Guarantee BookingHealth Price from:

About the department

The Department of Nuclear Medicine at the Medipol Mega University Hospital Istanbul offers the full range of radioisotope diagnostics and treatment of various pathologies. All procedures are carried out using ultramodern equipment, so that the patient receives a minimum dose of radiation. The department's specialists mostly perform scintigraphy, PET-CT, SPECT-CT, etc. These serve to imagine the anatomical structure and assess the function of the heart, kidneys, lungs, thyroid gland, liver, brain, skeletal bones, etc. The department is one of the few in Turkey with the cutting-edge imaging diagnostic devices, which guarantee the highest possible accuracy. The Chief Physician of the department is Prof. Dr. med. Tamer Atasever.

The department's range of medical services includes:

  • Diagnostics of respiratory diseases
    • Lung perfusion and ventilation scintigraphy (Tc99m MAA)
    • Postoperative FEV1 assessment (Tc99m MAA)
  • Diagnostics of diseases of the central nervous system 
    • PET brain scanning (18F-FDG)
    • Brain perfusion scintigraphy (Tc99m HMPAO)
    • Assessment of cerebral ventricular outflow (Tc99m DTPA)
    • Cisternography (Tc99m DTPA)
  • Diagnostics of cardiovascular diseases
    • Myocardial perfusion scintigraphy (Thallium 201 or Tc99m MIBI)
    • Myocardial PET scanning (assessment of myocardial performance using 18F-FDG)
    • Myocardial scintigraphy with 123I- or I 131-metaiodobenzylguanidine for the assessment of myocardial sympathetic innervation
    • Radionuclide ventriculography
  • Diagnostics of skeletal bone pathologies
    • Three-phase bone scanning
    • Whole-body bone scintigraphy
    • Bone PET-CT scanning (F18-NAF)
    • Arthroscintigraphy
  • Diagnostics of diseases of the endocrine and lacrimal glands
    • Thyroid scintigraphy
    • Parathyroid scintigraphy
    • Dacryoscintigraphy
  • Diagnostics of diseases of the genitourinary system
    • Dynamic renal scintigraphy (with DTPA or MAG3)
    • Static renal scintigraphy (DMSA)
    • Dynamic renal scintigraphy with ACE inhibitors (with DTPA or MAG3)
    • Scrotal scintigraphy
    • Scintigraphy to detect vesicoureteral reflux (direct and indirect)
  • Diagnostics of infectious diseases
    • Labeled white blood cell scintigraphy
    • Bone marrow scintigraphy using nanocolloid
  • Diagnostics of diseases of the hematopoietic system
    • Spleen imaging (using denatured red blood cells)
    • Hemangioma imaging
    • Lymphoid tissue scintigraphy
  • Cancer diagnostics
  • Radionuclide therapy
    • Radioiodine therapy (low dose and high dose)
    • Therapy using radioactive somatostatin analogues
    • SR-89 radionuclide therapy 
    • Sm-153 radionuclide therapy 
    • Re-186 radionuclide therapy 
    • P-32 radionuclide therapy 
    • I-131 MIBG radionuclide therapy 
    • Y-90 microsphere therapy
    • Anti-CD20 monoclonal antibody therapy with Y-90 microspheres
    • Radiosynoviorthesis
  • Other diagnostic and treatment methods

Curriculum vitae

Education

  • 1992 Faculty of Medicine, Ankara University (Nuclear Medicine).
  • 1984 Faculty of Medicine, Erciyes University.

Professional Career

  • 2010 - 2011 Gazi University.
  • 2006 - 2012 Work in the laboratory in Ankara.
  • 2003 and 1996 Gazi University.

Photo of the doctor: (c) Medipol Mega University Hospital Istanbul 


About hospital

Accommodation in hospital

Hospital accommodation

The patients and their families can stay at the Medipol Guest House, which is a 1-minute walk from the Medipol Mega University Hospital Istanbul.